TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein

Molecular Biology of the Cell

Volumn 9, Issue 12, 1998, Pages 3309-3319

  Shen, Xing ^a   Hu, Patrick Pei Chih ^a   Liberati, Nicole T ^a   Datto, Michael B ^a   Frederick, Joshua P ^a   Wang, Xiao Fan ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ONCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; ENZYME ASSAY; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0031773264     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.9.12.3309     Document Type: Article

References (61)

1. Abraham, S. E., Carter, M.C., and Moran, E. (1992). Transforming growth factor beta1 (TGF-beta1) reduces cellular levels of p34cdc2 and this effect is abrogated by adenovirus independently of the E1A-associated pRb binding activity. Mol. Biol. Cell 3, 655-665.
2. Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994). Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370, 226-229.
3. Baker, J., and Harland, R. (1996). A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10, 1880-1889.
4. Barrett, M.T., Schutte, M., Kern, S.E., and Reid, B.J. (1996). Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res. 56, 4351-4353.
5. Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A., and Livingston, D.M. (1996). Cooperation of Stat2 and p300/CBP in signaling by interferon. Nature 383, 344-347.
6. Borrow, J., et al. (1996). The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14, 33-41.
7. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima, T., Schulman, I.G., Juguilon, H., Montminy, M., and Evans, R.M. (1996). Role of CBP/p300 in nuclear receptor signaling. Nature 383, 99-103.
8. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G., and Whitman, M. (1997). Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89.
9. Chrivia, J.C., Kowk, R.P.S., Lamb, N., Hagiwara, M., Montminy, M.R., and Goodman, R.H. (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859.
10. Dallas, P.B., Yaciuk, P., and Moran, E. (1997). Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes. J. Virol. 71, 1726-1731.
11. Darnell, J.E.J. (1997). STATs and gene regulation. Science 277, 1630-1635.
12. Datto, M.B., Hu, P.P.-C., Kowalik, T.F., Yingling, J.M., and Wang, X.-F. (1997). The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell. Biol. 17, 2030-2037.
13. Datto, M.B., Li, Y., Panus, J., Howe, D.J., Xiong, Y., and Wang, X.-Y. (1995a). TGF-β mediated growth inhibition is associated with induction of the cyclin-dependent kinase inhibitor, p21. Proc. Natl. Acad. Sci. USA 92, 5545-5549.
14. Datto, M.B., Yu, Y., and Wang, X.-F. (1995b). Functional analysis of the transforming growth factor β responsive elements in the WAF1/ Cip1/p21 promoter. J. Biol. Chem. 270, 28623-28628.
15. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., and Gauthier, J.M. (1998). Direct binding of Smad3 and Smad4 to critical TGFb-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100.
16. Eckner, R., Ewen, M.E., Newsome, D., Gerdes, M., DeCaprio, J.A., Lawrence, J.B., and Livingston, D.M. (1994). Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8, 869-884.
17. Eppert, K., et al. (1996). MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552.
18. Feng, X.-H., Zhang, Y., Wu, R.-Y., and Derynck, R. (1998). The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev. 12, 2153-2163.
19. Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
20. Hahn, S.A., et al. (1996). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 273, 350-353.
21. Hannon, G.J., and Beach, D. (1994). p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371, 257-261.
22. Hata, A., Lo, R.S., Wotton, D., Lagna, G., and Massague, J. (1997). Mutations increasing autoinhibition inactivate tumor suppressors Smad2 and Smad4. Nature 388, 82-87.
23. Heldin, C.-H., Miyazono, K., and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
24. Hu, P.P.-C., Datto, M.B., and Wang, X.-F. (1998). Molecular mechanisms of transforming growth factor-β signaling. Endocr. Rev. 19, 349-363.
25. Janknecht, R., Wells, N.J., and Hunter, T. (1998). TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 12, 2114-2119.
26. Kamei, Y., et al. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
27. Kim, J., Johnson, K., Chen, H.J., Carroll, S., and Laughon, A. (1997). Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388, 304-308.
28. Kim, S.K., Fan, Y., Papadimitrakopoulou, V., Clayman, G., Hittelman, W.N., Hong, W., Lotan, R., and Mao, L. (1996). DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 56, 2519-2521.
29. Kraus, V.B., Moran, E., and Nevins, J.R. (1992). Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains. Mol. Cell. Biol. 32, 4391-4399.
30. Kwok, R.P.S., Lundblasd, J.R., Chrivia, J.C., Richards, J.P., Bachinger, H.P., Brennan, R.G., Roberts, S.G.E., Green, M.R., and Goodman, R.H. (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226.
31. Labbe, E., Silvestri, C., Hoodless, P.A., Wrana, J.L., and Attisano, L. (1998). Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell 2, 109-120.
32. Lagna, G., Hata, A., Hemmati-Brivanlou, A., and Massague, J. (1996). Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways. Nature 383, 832-836.
33. Lee, J.-S., Galvin, K.M., See, R.H., Eckner, R., Livingston, D.M., Moran, E., and Shi, Y. (1995). Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev. 9, 1188-1198.
34. Li, J.M., Datto, M.B., Shen, X., Hu, P.P., Yu, Y., and Wang, X.F. (1998a). Sp1, but not Sp3, functions to mediate promoter activation by TCF-β through canonical Sp1 binding sites. Nucleic Acids Res. 26, 2449-2456.
35. Li, J.-M., Nichols, M.A., Chandrasekharan, S., Xiong, Y., and Wang, X.-F. (1995). Transforming growth factor β activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270, 26750-26753.
36. Li, J.-M., Shen, X., Hu, P.P., and Wang, X.F. (1998b). Transforming growth/factor β stimulates the Human Immunodeficiency Virus 1 enhancer and requires NF-κB activity. Mol. Cell. Biol. 18, 110-121.
37. Liu, X.D., Sun, Y., Constantinescu, S.N., Karam, E., Weinberg, R.A., and Lodish, H.F. (1997). Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA 94, 10669-10674.
38. Lyons, R.M., and Moses, H.L. (1990). Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187, 467-473.
39. Macias-Silva, M., Abdollah, S., Hoodless, P., Pirone, R., Attisano, L., and Wrana, J. (1996). MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224.
40. Massague, J. (1990). The transforming growth factor-B family. Annu. Rev. Cell Biol. 6, 597-641.
41. Massague, J. (1998). TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791.
42. Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L.H., Livingston, D.M., and Dotto, G.P. (1995). Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 17710, 28491-19244.
43. Missero, C., Filvaroff, E., and Dotto, G.P. (1991). Induction of transforming growth factor 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins. Proc. Natl. Acad. Sci. USA 88, 3489-3493.
44. Moustakas, A., and Kardassis. D. (1998). Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95, 6733-6738.
45. Muraoka, M., Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Shitara, N., Chong, J.-M., Iwama, T., and Miyaki, M. (1995). p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12, 1565-1569.
46. Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., and Takahashi, T. (1996). Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 56, 2718-2720.
47. Ogrvzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996). The transcriptional activators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
48. Pietenpol, J.A., et al. (1990). TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61, 777-785.
49. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. (1995). Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9, 1831-1845.
50. Roberts, A.B., and Sporn, M.B. (1993). Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8, 1-9.
51. Schutte, M., et al. (1996). DPC4 gene in various tumor types. Cancer Res. 56, 2527-2530.
52. Swope, D.L., Mueller, C.L., and Chrivia, J.C. (1996). CREB-binding protein activates transcription through multiple domains. J. Biol. Chem. 271, 28138-28145.
53. Topper, J.N., DiChiara, M.R., Brown, J.D., Williams, A.J., Falb, D., Collins, T., and Gimbrone, M.A., Jr. (1998). CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in endothelial cells. Proc. Natl. Acad. Sci. USA 95, 9506-9511.
54. Wang, H.G., Rikitake, Y., Carter, M.C., Yaciuk, P., Abraham, S.E., Zerler, B., and Moran, E. (1993). Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67, 476-488.
55. Wrana, J.L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., and Massague, J. (1992). TGF-B signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
56. Yingling, J.M., Das, P., Savage, C., Zhang, M., Padgett, R.W., and Wang, X.-F. (1996). Mammalian dwarfins are phosphorylated in response to transforming growth factor β and are implicated in control of cell growth. Proc. Natl. Acad. Sci. USA 93, 8940-8944.
57. Yingling, J.M., Datto, M.B., Wong, C., Frederick, J.P., Liberati, N.T., and Wang, X.-F. (1997). The tumor suppressor, Smad-4, is a TGF-beta inducible, DNA binding protein. Mol. Cell. Biol. 17, 7019-7028.
58. Zawel, L., Dai, J.L., Buckhaults, P., Zhou, S., Kinzler K.W., Vogelstein, B., and Kern, S.E. (1998). Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617.
59. Zhang, Y., Feng, X.-H., Wu, R.-Y., and Derynck, R. (1996). Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383, 168-172.
60. Zhang, Y., Musci, T., and Derynck, R. (1997). The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr. Biol. 7, 270-276.
61. Zhong, H., Voll, R.E., and Ghosh, S. (1998). Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1, 661-671.